文献
J-GLOBAL ID:202102285121509098
整理番号:21A0084115
EGFR-変異非小細胞肺癌におけるEGFR-TKIの治療有効性を予測する同時遺伝子変異と他のバイオマーカー: レビュー【JST・京大機械翻訳】
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review
著者 (10件):
Guo Yijia
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Song Jun
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Wang Yanru
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Huang Letian
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Sun Li
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Zhao Jianzhu
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Zhang Shuling
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Jing Wei
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Ma Jietao
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
,
Han Chengbo
(Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, China)
資料名:
Frontiers in Oncology (Web)
(Frontiers in Oncology (Web))
巻:
10
ページ:
610923
発行年:
2020年
JST資料番号:
U7089A
ISSN:
2234-943X
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
スイス (CHE)
言語:
英語 (EN)